Newstral
Article
Star Tribune on 2022-07-20 22:45
FDA slaps Class 1 recall label on Minnesota-made syringe infusion pump
Related news
- FDA deal sharply limits Medtronic infusion pump manufacturing, salesStar Tribune
- Despite FDA warning from past recalls, agency OKs Medtronic's new insulin pumpStar Tribune
- Optum joins FDA, manufacturer in recalling infusion pumps that killed one patientStar Tribune
- UnitedHealth's Optum gets FDA warning letter over 'serious deficiencies' at infusion facilityStar Tribune
- FDA Issues Biosimilar Guidance for Label Carve-Outs and Supplementsjdsupra.com
- FDA rejects Intarcia's drug pumpbizjournals.com
- FDA creates 'added sugar' labelnwaonline.com
- Video Shows a Terrifying Drug Infusion Pump Hack in ActionWired.com
- Hackers Could Up Medication Doses Through Infusion Pump FlawsWired.com
- FDA: Medtronic must stop drug pump salesThe Salt Lake Tribune
- FDA Approves Medtronic’s New Automated Insulin Pumpwsj.com
- FDA clears an interoperable, automated insulin pumpengadget
- FDA Seeks to Provide Greater Insight on Off-Label Promotions of Pharmaceuticalsjdsupra.com
- FDA Supports Changing Date Label Phrasing on Foods—but Consumer Confusion Is Likely to Continuejdsupra.com
- FDA Extends Enforcement of New Nutrition Facts Label Another 6 Monthsjdsupra.com
- FDA Grants a Six-Month Enforcement Discretion Extension on Nutrition Fact Label Change Requirementsjdsupra.com
- More Time to Label — FDA Announces Enforcement Discretion, Updates Nutrition and Supplement Facts Implementationjdsupra.com
- FDA: Restaurants can omit Nutrition Facts label on packaged food during COVID-19jdsupra.com
- GFDA Proposes ‘Added Sugars’ on Nutrition LabelGuardian Liberty Voice
- Tobacco Companies Sue FDA Over Label Approvalsswtimes.com